---
title: "Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293664765.md"
description: "Bristol Myers Squibb (BMY) shares rose 1.23% to $61.51 on Thursday, outperforming the broader market as the S&P 500 and Dow Jones fell. However, BMY underperformed key competitors like Johnson & Johnson, Pfizer, and Abbott Laboratories, which all posted gains. The stock closed 2.19% below its 52-week high, with trading volume remaining significantly below its 50-day average."
datetime: "2026-07-23T20:37:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293664765.md)
  - [en](https://longbridge.com/en/news/293664765.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293664765.md)
---

# Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. (BMY) rallied 1.23% to $61.51 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.21% to 7,408.30 and Dow Jones Industrial Average falling 0.97% to 51,711.65.

Bristol Myers Squibb Co. closed 2.19% below its 52-week high of $62.89, which the company reached on March 2nd.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 1.42% to $259.27, Pfizer Inc. (PFE) rose 0.77% to $25.01, and Abbott Laboratories (ABT) rose 0.18% to $100.75.

Trading volume (7.6 M) remained 4.2 million below its 50-day average volume of 11.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-23-26 1637ET

### Related Stocks

- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)

## Related News & Research

- [MRA Advisory Group Buys Shares of 23,652 Bristol Myers Squibb Company $BMY](https://longbridge.com/en/news/295298608.md)
- [Bristol Myers to build $2.3 billion manufacturing site in Houston](https://longbridge.com/en/news/295410745.md)
- [Schrödinger (SDGR) Is Up 19.2% After AI Pact With BMS And Q2 Profitability - Has The Bull Case Changed?](https://longbridge.com/en/news/295629797.md)
- [AstraZeneca held talks with Bristol-Myers through spring, summer - FT](https://longbridge.com/en/news/295571239.md)
- [Why FTSE companies are heading for the exit](https://longbridge.com/en/news/295214428.md)